Showing all 6 results
Antacid & Anti-Ulcerant Tablets
FreeTechnical & Logistics Specifications
Parameter Specifications & Standards HS Code 3004.90.99 (Medicaments acting on the alimentary tract and metabolism) Pharmacopeia Compliance IP / BP / USP / EP Dosage Formats Enteric-Coated, Delayed-Release, Film-Coated, and Chewable Tablets Export Packaging 10 / 14 / 15 Tablets per Blister packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) or thick PVC/PVDC matrixes to protect against moisture ingress in Zone IVb tropical climates. Shelf-Life Stability Fully validated 36-Month real-time stability metrics Cinnarizine Tablets
FreeTechnical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
Technical Metric Specification Standard Active Ingredient Cinnarizine BP / USP / IP Dosage Form Immediate Release Tablets Available Strengths 25 mg (Vestibular) / 75 mg (Cerebrovascular) HS Code 3004.90.39 (Other CNS drugs) / 2933.59.90 Stability Validated for Zone IVb (Tropical) export markets Levocetirizine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The small, easy-to-swallow tablets are engineered for rapid disintegration to facilitate quick relief from acute allergic flares.
Active Ingredient Strength (Standard) Therapeutic Role Levocetirizine Dihydrochloride BP/USP 5 mg Potent H1-Receptor Antagonist Excipients Q.S. Microcrystalline Cellulose / Lactose Diluent & Disintegrant Coating Agent Q.S. Opadry® White Protective Film Coating Methimazole Tablets
FreeTechnical & Logistics Specifications
HS Code: 3004.90.39 (Medicaments containing hormones or other products – Antithyroid)
CAS Number: 60-56-0 (Methimazole / Thiamazole)
Dosage Form: Uncoated or Film-Coated Tablet
Packaging: Alu-Alu or Alu-PVC Blisters. Protects the sensitive API from environmental humidity; our high-barrier packaging ensures 24-month stability in Zone IVb tropical climates.
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Pheniramine Maleate Tablets
FreePheniramine Maleate Tablets IP 25 mg
Each Uncoated Tablet Contains :
Pheniramine Maleate IP 25 mg
